Skip to main content
    B

    Baxter International Inc (BAX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $25.77
    +0.23 (+0.88%)

    Market Cap: $13.21B

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Baxter International Inc (BAX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Baxter International (BAX) has a market cap of $13.21B and an enterprise value of $19.84B. Its return on invested capital of 0.41% compares with a 7.67% median across 10 similar companies. Its trailing P/E of 13.3x is below its 10-year median of 23.0x.

    Total Valuation

    Enterprise value is 50.15% above the market cap, as debt exceeds cash.

    Market Cap$13.21B
    Enterprise Value$19.84B
    Latest price (Nov 17, 2026)$25.77

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 27, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Next Ex-Dividend DateNov 27, 2026
    Next Payment DateJan 4, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 0.68% a year over 2 years.

    Shares Outstanding517.00M
    Shares Change (YoY)+0.58%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+0.68%

    Valuation Ratios

    Sales and book value multiples are 1.1x and 2.0x. Its year-end P/E ranged from 8.4x to 26.0x from 2016 to 2025.

    P/E Ratio13.3x
    Forward P/E12.1x
    P/S Ratio1.1x
    Forward P/S1.1x
    P/B Ratio2.0x
    P/FCF Ratio11.7x
    P/OCF Ratio8.1x
    PEG Ratio2.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 19.6x EBITDA and 17.5x free cash flow.

    EV / Sales1.7x
    EV / EBITDA19.6x
    EV / EBIT320.0x
    EV / FCF17.5x

    Price Statistics

    The stock is up 39.71% over 52 weeks and trades 4.97% above its 50-day average.

    Beta (1Y)1.05
    52-Week Change+39.71%
    1-Month Change+3.10%
    3-Month Change-3.25%
    6-Month Change+40.69%
    5-Year Change-70.87%
    10-Year Change-51.67%
    Total Return (1Y)+39.93%
    Total Return (3Y CAGR)-8.43%
    Total Return (5Y CAGR)-18.53%
    Return vs SPY (1Y)+30.62%
    Max Drawdown (1Y)-29.02%
    Max Drawdown (3Y)-62.45%
    Sharpe Ratio (1Y)0.84
    Correlation with SPY (1Y)0.34
    50-Day Average$24.55
    200-Day Average$21.69
    52-Week Range$15.72 to $29.99
    RSI (14 Days)53.8
    Average Volume (20 Days)7.15M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.79x current liabilities, and total debt is 1.32x shareholder equity.

    Current Ratio1.79x
    Quick Ratio1.19x
    Debt / Equity1.32x
    Debt / EBITDA8.46x
    Debt / FCF7.56x

    Returns and Efficiency

    Return on invested capital is 0.41% over the last 12 months, against a 5-year average of -1.36%.

    Return on Equity (ROE)-11.12%
    Return on Assets (ROA)-3.72%
    Return on Invested Capital (ROIC)0.41%
    Return on Capital Employed (ROCE)0.40%
    ROE (5Y Average)-4.06%
    ROA (5Y Average)-0.50%
    ROIC (5Y Average)-1.36%
    Asset Turnover0.57x
    Inventory Turnover3.56x
    Receivables Turnover6.38x
    Cash Conversion Cycle113 days

    Scores

    BAX has an Altman Z-Score of 2.43, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.43
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $11.61B over the last 12 months is up 5.33% from the 12 months before.

    Revenue$11.61B
    Revenue Growth (YoY)+5.33%
    Gross Profit$3.49B
    Operating Income-$221.00M
    Pretax Income-$187.00M
    Net Income-$723.00M
    EBITDA$1.02B
    EBIT$62.00M
    Reported EPS (TTM)$1.94

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 33.49% of the $19.41B in total assets.

    Cash and Equivalents$1.98B
    Total Debt$8.60B
    Net Debt$6.63B
    Net Debt Per Share$12.82
    Working Capital$3.02B
    Shareholder Equity$6.50B
    Book Value Per Share$12.58
    Tangible Book Value-$2.30B
    Total Assets$19.41B
    Total Liabilities$12.94B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $503.00M of capital spending, operating cash flow left $1.14B of free cash flow.

    Operating Cash Flow$1.64B
    Capital Expenditures$503.00M
    Free Cash Flow$1.14B
    FCF Per Share$2.20
    Depreciation and Amortization$955.00M
    Dividends Paid$102.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1.90%, against a 5-year average of -2.59%.

    Gross Margin30.09%
    Operating Margin-1.90%
    Pretax Margin-1.61%
    Net Margin-6.23%
    EBITDA Margin8.76%
    EBIT Margin0.53%
    FCF Margin9.79%
    Gross Margin (5Y Average)36.34%
    Operating Margin (5Y Average)-2.59%
    Net Margin (5Y Average)-0.44%

    Growth

    Revenue grew 3.79% a year over 3 years, and EPS fell 13.44% a year.

    Revenue Growth (3Y CAGR)+3.79%
    Revenue Growth (5Y CAGR)-0.75%
    EPS Growth (3Y CAGR)-13.44%
    EPS Growth (5Y CAGR)-5.98%
    FCF Growth (3Y CAGR)-26.44%
    FCF Growth (5Y CAGR)-22.12%
    Book Value Per Share Growth (2Y CAGR)-15.17%

    Revenue and profit by year

    Dividends and Yields

    BAX pays out 1.26% of earnings as dividends.

    Dividend Per Share (Annual)$0.04
    Dividend Yield0.16%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-23.25%
    Dividend Growth (5Y CAGR)-11.45%
    Payout Ratio1.26%
    FCF Payout Ratio8.97%
    Earnings Yield7.52%
    FCF Yield8.54%
    Buyback Yield-0.18%
    Shareholder Yield0.59%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on May 31, 2001.

    Last Split DateMay 31, 2001
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 11 similar companies, BAX has the 11th highest P/E and the lowest P/S.

    P/E Ratio13.3x vs 20.7x median
    P/S Ratio1.1x vs 2.8x median
    ROIC0.41% vs 7.67% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.33% vs +9.05% median
    Dividend Yield0.16% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.13% and EPS growth at -5.07% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.13%
    EPS Growth Forecast (2Y CAGR)-5.07%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BAX

    What is BAX's market cap?

    Baxter International has a market cap of $13.21B. Its enterprise value, which adds debt and subtracts cash, is $19.84B.

    What is BAX's P/E ratio?

    Baxter International has a trailing P/E ratio of 13.3x and a forward P/E of 12.1x.

    How many shares of BAX are outstanding?

    Baxter International has 517.00M shares outstanding. The count is up 0.58% from a year earlier.

    Does BAX pay a dividend?

    Yes. Baxter International pays $0.04 a share a year, a dividend yield of 0.16%.

    How much debt does BAX have?

    Baxter International has $8.60B of total debt and $1.98B of cash and equivalents, a net debt position of $6.63B.